KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 80 filers reported holding KEROS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $55,816,883 | -46.1% | 1,221,376 | -21.9% | 0.00% | -60.0% |
| Q1 2024 | $103,463,649 | +146.8% | 1,562,895 | +48.2% | 0.01% | +150.0% |
| Q4 2023 | $41,921,632 | +45.8% | 1,054,367 | +16.9% | 0.00% | 0.0% |
| Q3 2023 | $28,755,760 | -29.6% | 902,000 | -11.2% | 0.00% | 0.0% |
| Q2 2023 | $40,818,983 | +1.2% | 1,015,903 | +7.6% | 0.00% | 0.0% |
| Q1 2023 | $40,315,531 | -56.6% | 944,159 | -51.2% | 0.00% | -33.3% |
| Q4 2022 | $92,979,974 | +164.8% | 1,936,276 | +107.4% | 0.00% | +50.0% |
| Q3 2022 | $35,119,000 | +28.3% | 933,512 | -5.8% | 0.00% | 0.0% |
| Q2 2022 | $27,374,000 | -26.4% | 990,752 | +44.9% | 0.00% | 0.0% |
| Q1 2022 | $37,177,000 | -3.0% | 683,647 | +4.4% | 0.00% | 0.0% |
| Q4 2021 | $38,324,000 | +43.0% | 654,992 | -3.3% | 0.00% | +100.0% |
| Q3 2021 | $26,793,000 | -7.1% | 677,268 | -0.3% | 0.00% | -50.0% |
| Q2 2021 | $28,836,000 | -35.3% | 678,978 | -6.2% | 0.00% | -33.3% |
| Q1 2021 | $44,551,000 | +48.2% | 723,823 | +69.9% | 0.00% | +50.0% |
| Q4 2020 | $30,056,000 | +685.4% | 426,091 | +329.4% | 0.00% | – |
| Q3 2020 | $3,827,000 | +20.0% | 99,226 | +16.7% | 0.00% | – |
| Q2 2020 | $3,189,000 | – | 85,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |